Related Experiment Video
Updated: Jan 12, 2026
05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
1.2K
Telomeric G-quadruplex architecture and interactions with potential drugs
Claudia Sissi, Manlio Palumbo1
1Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo, 5, 35131 Padova (Italy). claudia.sissi@unipd.it.
Current Pharmaceutical Design
|July 1, 2014
Summary
Scientists explore new nucleic acid structures, focusing on telomeric G-quadruplex DNA and RNA. They are designing synthetic ligands for potential pharmacological applications targeting these structures.
Area of Science:
- Structural biology
- Medicinal chemistry
- Molecular biology
Background:
- Novel nucleic acid folding architectures offer insights into structural diversity and functional roles.
- Physiological and pathological processes can be modulated by ligands interacting with specific nucleic acid sequences.
Purpose of the Study:
- To review recent advancements in understanding telomeric G-quadruplex DNA and RNA structures.
- To discuss the rational design and development of synthetic ligands for pharmacological applications targeting these structures.
Main Methods:
- Literature review of recent studies on telomeric G-quadruplex structures.
- Analysis of rational drug design principles for synthetic ligand development.
Main Results:
- G-quadruplex structures exhibit diverse architectures with significant functional implications.
- Synthetic ligands can be rationally designed to interact with specific G-quadruplex targets.
Conclusions:
- Understanding telomeric G-quadruplexes is crucial for developing novel therapeutic strategies.
- Targeting these structures with synthetic ligands holds promise for pharmacological applications.
Related Concept Videos
02:41Telomeres and Telomerase
26.8K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.8K
01:19RNA Structure
7.1K
The basic structure of RNA consists of a string of ribonucleotides attached by phosphodiester bonds. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA) involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three...
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA) involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three...
7.1K
01:26Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K